Cargando…
Identifying hepatocellular carcinoma patients with survival benefits from surgery combined with chemotherapy: based on machine learning model
BACKGROUND: Hepatocellular carcinoma (HCC) is still fatal even after surgical resection. The purpose of this study was to analyze the prognostic factors of 5-year survival rate and to establish a model to identify HCC patients with gain of surgery combined with chemotherapy. METHODS: All patients wi...
Autores principales: | Hu, Jie, Gong, Ni, Li, Dan, Deng, Youyuan, Chen, Jiawei, Luo, Dingan, Zhou, Wei, Xu, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714169/ https://www.ncbi.nlm.nih.gov/pubmed/36451200 http://dx.doi.org/10.1186/s12957-022-02837-2 |
Ejemplares similares
-
Identifies Immune Feature Genes for Prediction of Chemotherapy Benefit in Cancer
por: Bai, Yuquan, et al.
Publicado: (2022) -
Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future
por: Sarkar, Devanand
Publicado: (2022) -
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma
por: Iwamoto, Hideki, et al.
Publicado: (2021) -
Comparison of Survival Benefits of Combined Chemotherapy and Radiotherapy Versus Chemotherapy Alone for Uterine Serous Carcinoma: A Meta-analysis
por: Lin, Yanying, et al.
Publicado: (2017) -
Combination surgery for hepatocellular carcinoma: slashing and burning to improved survival
por: McVey, John C., et al.
Publicado: (2020)